Functional evidence for P2X receptors in isolated human vagus nerve

Anesthesiology

Volumn 99, Issue 1, 2003, Pages 232-235

  Lang, Philip M ^a   Sippel, Wolfgang ^a   Schmidbauer, Stefan ^a   Irnich, Dominik ^a   Grafe, Peter ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PURINE P2X RECEPTOR;

ACTION POTENTIAL; ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CALCIUM CELL LEVEL; CASE REPORT; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONMYELINATED NERVE; PRIORITY JOURNAL; VAGUS NERVE;

ACTION POTENTIALS; ADENOSINE TRIPHOSPHATE; AGED; AUTONOMIC NERVOUS SYSTEM; CALCIUM; ELECTRIC STIMULATION; ELECTRODES; ELECTROPHYSIOLOGY; FLUORESCENT DYES; HUMANS; MALE; MIDDLE AGED; RECEPTORS, PURINERGIC P2; VAGUS NERVE;

EID: 0037772617     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200307000-00038     Document Type: Article

References (26)

1. Dunn PM, Zhong Y, Burnstock G: P2X receptors in peripheral neurons. Prog Neurobiol 2001; 65:107-34
2. Hamilton SG, McMahon SB: ATP as a peripheral mediator of pain. J Auton Nerv Syst 2000; 81:187-94
3. Honore P, Mikusa J, Bianchi B, McDonald H, Cartmell J, Faltynek C, Jarvis MF: TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics. Pain 2002:96:99-105
4. Burnstock G: Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin Med 2002; 2:45-53
5. Bleehen T, Keele CA: Observations on the algogenic actions of adenosine compounds on the human blister base preparation. Pain 1977; 3:367-77
6. Hamilton SG, Warburton J, Bhattacharjee A, Ward J, McMahon SB: ATP in human skin elicits a dose-related pain response which is potentiated under conditions of hyperalgesia. Brain 2000; 123(Pt 6):1238-46
7. Trezise DJ, Kennedy I, Humphrey PP: The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5′-triphosphate. Br J Pharmacol 1994; 112:282-8
8. Irnich D, Burgstahler R, Bostock H, Grafe P: ATP affects both axons and Schwann cells of unmyelinated C fibres. Pain 2001; 92:343-50
9. Page AJ, Martin CM, Blackshaw LA: Vagal mechanoreceptors and chemoreceptors in mouse stomach and esophagus. J Neurophysiol 2002; 87:2095-103
10. Lang PM, Tracey DJ, Irnich D, Sippel W, Grafe P: Activation of adenosine and P2Y receptors by ATP in human peripheral nerve. Naunyn Schmiedebergs Arch Pharmacol 2002; 366:449-57
11. 2+ transients in human sural nerve. Neuroreport 1996; 7:1289-92
12. 2+ transients in nociceptive human C fibres. Pain 1999; 81:317-22
13. von Kügelgen I, Wetter A: Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol 2000; 362:310-23
14. O'Reilly BA, Kosaka AH, Knight GF, Chang TK, Ford AP, Rymer JM, Popert R, Burnstock G, McMahon SB: P2X receptors and their role in female idiopathic detrusor instability. J Urol 2002; 167:157-64
15. North RA, Surprenant A: Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 2000; 40:563-80
16. Thomas S, Virginio C, North RA, Suprenant A: The antagonist trinitrophenyl-ATP reveals co-existence of distinct P2X receptor channels in rat nodose neurones. J. Physiol 1998; 509(Pt 2):411-7
17. Spelta V, Jiang LH, Surprenant A, North RA: Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors. Br J Pharmacol 2002; 135:1524-30
18. Miras-Portugal MT, Gualix J, Mateo J, Diaz-Hernandez M, Gomez-Villafuertes R, Castro E, Pintor J: Diadenosine polyphosphates, extracellular function and catabolism. Prog Brain Res 1999; 120:397-409
19. McDonald HA, Chu KL, Bianchi BR, McKenna DG, Briggs CA, Burgard EC, Lynch KJ, Faltynek C, Cartmell J, Jarvis MF: Potent desensitization of human P2X3 receptors by diadenosine polyphosphates. Eur J Pharmacol 2002; 435:135-42
20. Hilliges M, Weidner C, Schmelz M, Schmidt R, Orstavik K, Torebjork E, Handwerker H: ATP responses in human C nociceptors. Pain 2002; 98:59-68
21. Zimmermann H: Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 2000; 362:299-309
22. Irnich D, Tracey DJ, Polten J, Burgstahler R, Grafe P: ATP stimulates peripheral axons in human, rat and mouse: Differential involvement of A(2B) adenosine and P2X purinergic receptors. Neuroscience 2002; 110:123-9
23. Janig W, Habler HJ: Physiology and pathophysiology of visceral pain. Schmerz 2002; 16:429-46
24. Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L, Hedley L, Lachnit WG, Burnstock G, McMahon SB, Ford AP: Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 2000; 407:1011-5
25. Burnstock G: Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci 2001; 22:182-8
26. Jacobson KA, Jarvis MF, Williams M: Purine and pyrimidine (P2) receptors as drug targets. J Med Chem 2002; 45:4057-93